Dokument: COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey
Titel: | COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey | |||||||
URL für Lesezeichen: | https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=68690 | |||||||
URN (NBN): | urn:nbn:de:hbz:061-20250218-115014-1 | |||||||
Kollektion: | Publikationen | |||||||
Sprache: | Englisch | |||||||
Dokumententyp: | Wissenschaftliche Texte » Artikel, Aufsatz | |||||||
Medientyp: | Text | |||||||
Autoren: | Kernder, Anna [Autor] Filla, Tim [Autor] Groot, Kirsten de [Autor] Hellmich, Bernhard [Autor] Holle, Julia [Autor] Lamprecht, Peter [Autor] Moosig, Frank [Autor] Ruffer, Nikolas [Autor] Specker, Christof [Autor] Vordenbäumen, Stefan [Autor] | |||||||
Dateien: |
| |||||||
Stichwörter: | patient survey, health care, vaccination coverage, systemic vasculitis, COVID-19 | |||||||
Beschreibung: | Objective: To analyze the impact of the COVID-19 pandemic on medical care and vaccination acceptance of vasculitis patients in Germany.
Methods: A web-based national survey was developed by rheumatology centers and vasculitis patient advocacy groups. The survey was distributed nationwide by mail and flyers and could be accessed via a QR-code or weblink from December 2021 to April 2022. Descriptive statistics [mean, median, standard derivation (SD), 25%, 75% quantile] were calculated. 95% confidence intervals were presented for responses that were directly related to the impact of COVID-19 on parameters associated with vasculitis patient care. Results: The online survey was completed by 117 patients with small and large vessel vasculitis [granulomatosis with polyangiitis (n = 69), eosinophilic granulomatosis with polyangiitis (n = 16), microscopic polyangiitis (n = 12), giant cell arteritis (n = 17) and Takayasu's arteritis (n = 3)]. Prescheduled rheumatological appointments had been canceled due to the COVID-19 pandemic in 12.6% of the respondents [95% confidence interval (CI), 7.3–20.0%); in 9% (95% CI, 4.5–15.6%)] appointments had been replaced by digital services. Therapeutic regimens were changed (shifted, reduced, or discontinued) due to the pandemic in 15.5% (95% CI 9.5–22.2%). Vaccination coverages were generally high compared to patients with other rheumatic diseases and the general population. Highest vaccination coverage was observed against COVID-19 (98.1% 95% CI 93.9–99.6%). Conclusion: Vasculitis patients experienced changes in medical care during COVID-19 pandemic such as cancelation of prescheduled rheumatology appointments and modifications in therapeutic regimens. The overall acceptance rate for vaccination was comparatively high, particularly for vaccination against COVID-19. | |||||||
Rechtliche Vermerke: | Originalveröffentlichung:
Kernder, A. L., Filla, T., de Groot, K., Hellmich, B., Holle, J., Lamprecht, P., Moosig, F., Ruffer, N., Specker, C., Vordenbäumen, S., Schneider, M., & Chehab, G. (2023). COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey. Frontiers in Medicine, 9, Article 1103694. https://doi.org/10.3389/fmed.2022.1103694 | |||||||
Lizenz: | ![]() Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz | |||||||
Fachbereich / Einrichtung: | Medizinische Fakultät | |||||||
Dokument erstellt am: | 18.02.2025 | |||||||
Dateien geändert am: | 18.02.2025 |